293 related articles for article (PubMed ID: 16045796)
21. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
Rudolphus A; Kramps JA; Mauve I; Dijkman JH
Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
[TBL] [Abstract][Full Text] [Related]
22. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice.
Taooka Y; Maeda A; Hiyama K; Ishioka S; Yamakido M
Am J Respir Crit Care Med; 1997 Jul; 156(1):260-5. PubMed ID: 9230758
[TBL] [Abstract][Full Text] [Related]
23. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Okamoto Y; Kikkawa H; Asano S; Kinoshita M
J Clin Pathol; 2007 Mar; 60(3):283-9. PubMed ID: 16751304
[TBL] [Abstract][Full Text] [Related]
24. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.
Wu Z; Yang L; Cai L; Zhang M; Cheng X; Yang X; Xu J
Respir Res; 2007 Jan; 8(1):1. PubMed ID: 17207287
[TBL] [Abstract][Full Text] [Related]
25. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
[TBL] [Abstract][Full Text] [Related]
26. Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters.
Mitsuhashi H; Asano S; Nonaka T; Hamamura I; Masuda K; Kiyoki M
Am J Respir Crit Care Med; 1996 Jan; 153(1):369-74. PubMed ID: 8542145
[TBL] [Abstract][Full Text] [Related]
27. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema.
Iizuka T; Ishii Y; Itoh K; Kiwamoto T; Kimura T; Matsuno Y; Morishima Y; Hegab AE; Homma S; Nomura A; Sakamoto T; Shimura M; Yoshida A; Yamamoto M; Sekizawa K
Genes Cells; 2005 Dec; 10(12):1113-25. PubMed ID: 16324149
[TBL] [Abstract][Full Text] [Related]
28. Lung cytokine production in bleomycin-induced pulmonary fibrosis.
Phan SH; Kunkel SL
Exp Lung Res; 1992; 18(1):29-43. PubMed ID: 1374023
[TBL] [Abstract][Full Text] [Related]
29. AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase.
Stevens T; Ekholm K; Gränse M; Lindahl M; Kozma V; Jungar C; Ottosson T; Falk-Håkansson H; Churg A; Wright JL; Lal H; Sanfridson A
J Pharmacol Exp Ther; 2011 Oct; 339(1):313-20. PubMed ID: 21791628
[TBL] [Abstract][Full Text] [Related]
30. Genetic deficiency in alpha 1 proteinase inhibitor (alpha 1 PI) associated with emphysema.
Martorana PA; Lungarella G
Lab Anim Sci; 1998 Oct; 48(5):460-2. PubMed ID: 10090058
[No Abstract] [Full Text] [Related]
31. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
32. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
33. Palifermin induces alveolar maintenance programs in emphysematous mice.
Yildirim AO; Muyal V; John G; Müller B; Seifart C; Kasper M; Fehrenbach H
Am J Respir Crit Care Med; 2010 Apr; 181(7):705-17. PubMed ID: 20007933
[TBL] [Abstract][Full Text] [Related]
34. Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure.
Churg A; Zhou S; Preobrazhenska O; Tai H; Wang R; Wright JL
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):268-76. PubMed ID: 18723441
[TBL] [Abstract][Full Text] [Related]
35. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.
Churg A; Wang RD; Xie C; Wright JL
Am J Respir Crit Care Med; 2003 Jul; 168(2):199-207. PubMed ID: 12689849
[TBL] [Abstract][Full Text] [Related]
36. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
Baecher-Allan CM; Barth RK
Reg Immunol; 1993; 5(3-4):207-17. PubMed ID: 7694632
[TBL] [Abstract][Full Text] [Related]
37. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
[TBL] [Abstract][Full Text] [Related]
38. A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats.
Kuraki T; Ishibashi M; Takayama M; Shiraishi M; Yoshida M
Am J Respir Crit Care Med; 2002 Aug; 166(4):496-500. PubMed ID: 12186827
[TBL] [Abstract][Full Text] [Related]
39. Macrophage colony-stimulating factor aggravates rather than regenerates emphysematous lungs in mice.
Ishikawa T; Aoshiba K; Yokohori N; Nagai A
Respiration; 2006; 73(4):538-45. PubMed ID: 16601323
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin.
Cattani-Cavalieri I; Reis AG; Kennedy-Feitosa E; Pinho-Ribeiro V; Lanzetti M; Gitirana LB; Romana-Souza B; Porto LC; Valença SS
Inflammation; 2017 Oct; 40(5):1487-1496. PubMed ID: 28534139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
